New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling

Keesha E. Erickson, Oleksii S. Rukhlenko, Richard G Posner, William S. Hlavacek, Boris N. Kholodenko

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.

Original languageEnglish (US)
JournalSeminars in Cancer Biology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Neoplasms
Protein Isoforms
Technology
Pharmaceutical Preparations
Genes

Keywords

  • ERK cascade
  • Mathematical modeling
  • Mechanistic modeling
  • RAS
  • Systems biology

ASJC Scopus subject areas

  • Cancer Research

Cite this

New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling. / Erickson, Keesha E.; Rukhlenko, Oleksii S.; Posner, Richard G; Hlavacek, William S.; Kholodenko, Boris N.

In: Seminars in Cancer Biology, 01.01.2018.

Research output: Contribution to journalArticle

Erickson, Keesha E. ; Rukhlenko, Oleksii S. ; Posner, Richard G ; Hlavacek, William S. ; Kholodenko, Boris N. / New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling. In: Seminars in Cancer Biology. 2018.
@article{6e56bc915d2b4e94ae66e8837137cf1a,
title = "New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling",
abstract = "RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.",
keywords = "ERK cascade, Mathematical modeling, Mechanistic modeling, RAS, Systems biology",
author = "Erickson, {Keesha E.} and Rukhlenko, {Oleksii S.} and Posner, {Richard G} and Hlavacek, {William S.} and Kholodenko, {Boris N.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.semcancer.2018.02.008",
language = "English (US)",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling

AU - Erickson, Keesha E.

AU - Rukhlenko, Oleksii S.

AU - Posner, Richard G

AU - Hlavacek, William S.

AU - Kholodenko, Boris N.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.

AB - RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.

KW - ERK cascade

KW - Mathematical modeling

KW - Mechanistic modeling

KW - RAS

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=85042873628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042873628&partnerID=8YFLogxK

U2 - 10.1016/j.semcancer.2018.02.008

DO - 10.1016/j.semcancer.2018.02.008

M3 - Article

C2 - 29518522

AN - SCOPUS:85042873628

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

ER -